Dragonfly Hikes on Airstream Hookup
Dragonfly Energy Holdings Corp. (NASDAQ: DFLI) shares gathered strength Tuesday. The Reno-based company, an industry leader in energy storage and battery technology and maker of Battle Born Batteries®, today announced an expanded partnership with Airstream, Inc®.
With Battle Born Batteries now standard in Airstream’s Model Year 2026 Interstate and Atlas motorized lines, Battle Born Batteries are now used across Airstream’s entire product lineup both as standard features as well as optional upgrades.
This morning’s news release reveals this expansion builds on a long-standing collaboration between two American brands committed to innovation, reliability, and enabling off-grid freedom.
“Our work with Dragonfly Energy has evolved into a strong and productive partnership over the years,” said Chris Rahrig, Vice President of Supply Chain at Airstream.
“As we expand our capabilities in off-grid travel, it’s essential to align with partners who prioritize power independence, quality, and user experience.”
The expanded collaboration now includes seamless integration of Battle Born lithium iron phosphate battery systems into the standard Advanced Power System and optional Advanced Power Plus Packages in Airstream’s Mercedes-Benz® lineup of motorized products, officially unveiled at the Airstream International Dealer Meeting in July.
Designed to meet rising demand for high-capacity energy solutions, these factory-installed systems are optimized for longevity and robust off-grid capability.
DFLI shares spiked three cents, or 9.7%, to 31 cents.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


